Biosite® Inc. Web Site -- Cardiac Panel

By: Alere  09-12-2011

Triage® Cardiac Panel

Rapid, actionable information to aid in the diagnosis of acute myocardial infarction

Finally, technology that has caught up with your needs.
Rapid, quantitative measurement of CK-MB, myoglobin, and troponin I to aid in the diagnosis of acute myocardial infarction.

  • Simultaneous cardiac marker results from whole blood in approximately 15 minutes
  • Enables triage decisions in under two hours when used with accelerated protocol 1
    • Faster diagnosis of patients with nondiagnostic ECG1,2,3
    • Rapid, accurate rule out of acute myocardial infarction1,2,3
    • Objective information for appropriate disposition of patients1,2,3
    • Faster triage decisions to care pathways1,2,3
    • Decreased length of stay in emergency department1
  • Designed for compatibility with busy emergency departments and physician practices
  • Simple one-step testing
  • Compact and portable instrument
  • Low maintenance
  • Built-in quality control features


Other products and services from Alere

09-12-2011

Biosite® Inc. Web Site -- D-Dimer Test

A rapid, quantitative immunoassay to aid in the assessment and evaluation of patients suspected of having disseminated intravascular coagulation and thromboembolic events including pulmonary embolism and deep vein thrombosis. Performed on the Triage Meters.


09-12-2011

Biosite® Inc. Web Site -- Products

Through combined expertise in diagnostic discovery and commercialization, Biosite is focused on developing novel diagnostics tests that are capable of immediately and accurately diagnosing and assessing critical conditions, which can take several hours or even days using conventional testing methods.


09-12-2011

Biosite® Inc. Web Site -- Profiler Shortness of Breath

The Triage® Profiler Shortness of Breath Panel provides rapid risk assessment and differential diagnosis of patients presenting to the emergency department with shortness of breath and risk assessment of patients with acute coronary syndromes. Troponin I, CK-MB, myoglobin, BNP and D-dimer each provide unique clinical information, and the panel approach maximizes the strengths of each marker.


09-12-2011

Biosite® Inc. Web Site -- TOX Drug Screen -- TOX Drug Screen

According to the National Academy of Clinical Biochemistry, Laboratory Medicine Practice Guidelines, stat toxicology assays required to support an ED should have a turnaround time of one hour or less. The Value of Point-of-Care Drug Testing Nearly every day patients are treated in emergency departments across the country for complications due to drug overdose.


09-12-2011

Biosite® Inc. Web Site -- Triage System

An immunoassay for use as an aid in the diagnosis of acute myocardial infarction, the diagnosis and assessment of severity of congestive heart failure, and the risk stratification of patients with acute coronary syndromes and congestive heart failure. An immunoassay for the quantitative determination of CK-MB, myoglobin, and troponin I in whole blood or plasma, as an aid in the diagnosis of acute myocardial infarction.


09-12-2011

Biosite® Inc. Web Site -- Triage® BNP Test

The Triage BNP Test is intended for use with the Triage Meters for the rapid in vitro quantitative measurement of B-Type Natriuretic Peptide in human whole-blood or plasma specimens using EDTA as the anticoagulant. 98 percent diagnostic accuracy in initial studies versus all other clinical findings in patients with or without disease history3.